Email
Print
Imaging Biomarkers Market Overview
Imaging Biomarkers Market size reached $6,642 million in 2021, growing at a CAGR of 14.1% during the forecast period 2022-2027. A biomarker is a biological molecule found in tissue, blood, or other body fluids, which marks the presence of a normal or an abnormal process, or of a condition or disease. An imaging biomarker is a biologic feature, or biomarker detectable in an image. In medicine, an imaging biomarker is a feature of an image relevant to a patient's diagnosis. Imaging biomarkers (IBs) are vital in the treatment of cancer, Alzheimer and other diseases. Clinical TNM stage, objective response, and left ventricular ejection fraction are all IBs utilized in cancer treatment. Imaging biomarkers are used for the real visualization of medication pharmacodynamics effects and treatment responses. It is essential for ensuring patient safety and determining the efficacy of a treatment. Imaging biomarkers offer non-invasive methods that can be used in both labs and clinics. The rise in illness awareness, greater screening and awareness among patients, and technological breakthroughs such as virtualization of imaging biomarkers and big data technologies and increased service improvements are the factors that are set to drive the growth of the Imaging Biomarkers Market for the period 2022-2027.
Report Coverage
The report: “Imaging Biomarkers Market – Forecast (2022-2027)”, by IndustryARC covers an in-depth analysis of the following segments of the Imaging Biomarkers Market.
By Technology: Positron Emission Tomography (PET), Ultrasound, Magnetic Resonance Imaging, Computed Tomography (CT), Single-Photon Emission Computerized Tomography (SPECT), and Others.
By Application: Personalized Medicine, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).
Key Takeaways
- Geographically, the North America Imaging Biomarkers Market accounted for the highest revenue share in 2021, and it is poised to dominate over the period 2022-2027 owing to the growing focus on technological advancements like virtualization of imaging biomarkers, and technologies like Big Data in the region.
- The ability to enable the characterization of patient populations to which new drugs reach intended targets is driving the Drug Discovery and Development segment. However, the difficulties in developing reliable imaging biomarkers are one of the major factors that are said to reduce the growth of the Imaging Biomarkers Market.
- In addition, according to the Alzheimer's Disease Facts and Figures Report, more than 5.8 million persons in America suffered from dementia caused by Alzheimer's disease in 2019, with the majority of patients being over 75 years old, which in turn is contributing to the growth of the Imaging Biomarkers Market.
- Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Imaging Biomarkers Market report.
Imaging Biomarkers: Market Share (%) by region, 2021
For more details on this report - Request for Sample
Imaging Biomarkers Market Segment Analysis – By Technology:
Based on Technology, the Magnetic Resonance Imaging segment accounted for the largest revenue market share in 2021 for Imaging Biomarkers Market as they are more dynamic and can be adjusted to derive several parameters based on several intrinsic features of tissue, such as T1- and T2 relaxation times, proton density, diffusion, and water-fat fraction. Magnetic Resonance Imaging is a useful diagnostic tool for detecting disorders such as lesions in the spine, cancers, and strokes that affect the blood vessels and brain. The growing focus on developing improved MR image processing techniques to find MR-related biomarkers that are utilized to improve the accuracy of clinical diagnosis of Alzheimer's disease is driving the growth of the Imaging Biomarkers Market. The Computed Tomography segment is predicted to grow with the fastest CAGR of 17.2% in the forecast period 2022-2027. Fully automated quantitative tissue biomarkers obtained from CT scans outperform existing clinical indicators for presymptomatic risk classification for potential major adverse events and add opportunistic value to CT images used for other purposes is supporting the segment growth.
Imaging Biomarkers Market Segment Analysis – By Application:
Based on Application, the Disease Diagnosis segment accounted for the largest revenue market share in 2021 for Imaging Biomarkers Market. The precision of the measurements in disease diagnosis is influenced by the image acquisition parameters (different centers, vendors, protocols, patient preparation), and image processing methods (computer algorithm, influence of human interaction) are fuelling segment growth. The Drug Discovery and Development segment is predicted to grow with the fastest CAGR of 17.7% in the forecast period 2022-2027. This is owing to their ability to enable the characterization of patient populations to which new drugs reach intended targets. Imaging modalities such as magnetic resonance imaging, computed tomography, and positron emission tomography offer significant insights into the bioactivity, pharmacokinetics, and dosing of drugs, in addition to supporting registration applications. Imaging biomarkers are very familiar to drug developers such as bone mineral density in osteoporosis, left ventricular ejection fraction in cardiology; objective tumor response carotid intima-media thickness in atherosclerosis, which is driving the growth of the Imaging Biomarkers Market.
Imaging Biomarkers Market Segment Analysis – By Geography
Based on Geography, North America Imaging Biomarkers accounted for the 41% revenue share in 2021. The growing awareness of the disease, the increased screening, and the rising advancements are set to drive the growth of the regional market. The increased technological advancements like virtualization of imaging biomarkers, and technologies like Big Data are making way for highly complex imaging techniques. Scientists in the region are exploring more about the structural and functional differences of neurological diseases. Moreover, there has been an increase in biobanks which have helped to address unmet needs in oncology, neuroscience, and cardiovascular disease. An increasing number of research and development activities for improving the effectiveness of neurological Biomarkers are driving the growth of the Imaging Biomarkers Market. The Asia-Pacific market is poised to grow with the fastest CAGR in the forecast period 2022-2027. The rapid increase in health insurance coverage is the key driving factor as they ensure access to high-quality care while protecting high medical expenses. The rising prevalence of colon or colorectum cancer among men and women both and growing technological developments in Spain are further driving the Imaging Biomarkers market.
Imaging Biomarkers Market Drivers
Rising Incidences Of Chronic Diseases Such As Cancer, Including Lung, Liver, And Stomach Cancer Aids In Market Growth:
The demand for Imaging Biomarkers is growing owing to the rising number of cancer cases, as Imaging biomarkers (IBs) are essential in the treatment of cancer patients. Clinical TNM stage, objective response, and left ventricular ejection fraction are all IBs utilized in cancer daily. Biomarkers like CT, MRI, PET, and ultrasonography are widely employed in cancer research and medication development. The rising number of cancer cases is predicted to increase the demand for improved personalized cancer medicines to treat patients effectively, which is propelling the growth of the Imaging Biomarkers Market.
The Recognition Of Imaging Biomarkers To Play A Larger Role In The Future Of Tailored Medicine Is Boosting The Market Growth:
Imaging Biomarkers, which use genomic data to help forecast certain health conditions, are well-known in the healthcare business and have paved the way for a new era of "personalized" medicine. These biomarkers help frontline clinicians improve patient care in ways that lead to preventive measures, such as predicting the likelihood of developing certain types of cancer, but they also help life science companies find research study candidates who are most likely to succeed when given a specific therapy. Imaging biomarkers that are developed through the science of radionics are playing a larger role in the future of tailored medicine development are now recognized in the business, which is driving the growth of the Imaging Biomarkers Market.
Imaging Biomarkers Market Challenge:
Difficulties In Developing Reliable Imaging Biomarker Is Hindering The Market Growth:
The lack of precise, non-invasive, image-based tissue characterization; the micro resolution, which allows for earlier identification of a lesion, a microscopic metastasis (less than 0.2mm), or the exact borders of a detected lesion is restricting the market growth. The development of reliable imaging biomarkers is fraught with difficulties. It necessitates proving that one or more functional metrics accurately reflect the biology of interest, as well as identifying a measurement procedure that can be used in a consistent and repeatable manner. The measurement method's specification can be difficult, like in the case of MRI, where there are many experimental variables. The signal's influence, as a result, optimizing and then standardizing the task of developing functional imaging measurement methods is difficult, which is one of the major factors that is estimated to reduce the growth of the Imaging Biomarkers market.
Imaging Biomarkers Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Imaging Biomarkers Market. Imaging Biomarkers Market top 10 companies are:
- Siemens Healthineers
- ICON Plc
- Invicro LLC
- Median Technologies
- PI Solutions Group GmbH
- IXICO plc
- Bioxydyn Ltd.
- Zionexa
- Imabiotech
- BRAINOMIX
Recent Developments
- In June 2021, ImaBiotech Group has expanded its Bioanalytical Pharmaceutical Services in North America with Pyxant Labs Colorado. The company has expanded with the integration of the expertise, innovation, and analytical platforms of the companies. The expansion is done to form a leading global bioanalytical services provider by encompassing unique proprietary drug and biomarker imaging to provide a unique offering to pharmaceutical companies.
- In March 2021, IXICO plc has entered into a partnership with Cyclerion Therapeutics, Inc. The partnership is made to support the company's Phase IIa clinical trial to investigate CY6463 for the treatment of individuals with Alzheimer's disease. The partnership objective is to provide advanced neuroimaging solutions.
- In March 2021, Invicro LLC has entered into a partnership with Amazon Web Services, Inc. to support the build-out of the company’s LATTICETM initiative. It is a ground-breaking integrated diagnostic data platform. LATTICETM combines genomics and radiology data along with other critical information to uncover clinically relevant biomarkers and create the next generation of diagnostic tests.
Related Reports:
Biomarkers Market - Forecast (2022 - 2027)
Report Code: HCR 0059
Cancer Biomarkers Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2022 - 2027
Report Code: HCR 0194
For more Lifesciences and Healthcare related reports, please click here
Table 1: Imaging Biomarker Market Overview 2023-2030
Table 2: Imaging Biomarker Market Leader Analysis 2023-2030 (US$)
Table 3: Imaging Biomarker Market Product Analysis 2023-2030 (US$)
Table 4: Imaging Biomarker Market End User Analysis 2023-2030 (US$)
Table 5: Imaging Biomarker Market Patent Analysis 2013-2023* (US$)
Table 6: Imaging Biomarker Market Financial Analysis 2023-2030 (US$)
Table 7: Imaging Biomarker Market Driver Analysis 2023-2030 (US$)
Table 8: Imaging Biomarker Market Challenges Analysis 2023-2030 (US$)
Table 9: Imaging Biomarker Market Constraint Analysis 2023-2030 (US$)
Table 10: Imaging Biomarker Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Imaging Biomarker Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Imaging Biomarker Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Imaging Biomarker Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Imaging Biomarker Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Imaging Biomarker Market Value Chain Analysis 2023-2030 (US$)
Table 16: Imaging Biomarker Market Pricing Analysis 2023-2030 (US$)
Table 17: Imaging Biomarker Market Opportunities Analysis 2023-2030 (US$)
Table 18: Imaging Biomarker Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Imaging Biomarker Market Supplier Analysis 2023-2030 (US$)
Table 20: Imaging Biomarker Market Distributor Analysis 2023-2030 (US$)
Table 21: Imaging Biomarker Market Trend Analysis 2023-2030 (US$)
Table 22: Imaging Biomarker Market Size 2023 (US$)
Table 23: Imaging Biomarker Market Forecast Analysis 2023-2030 (US$)
Table 24: Imaging Biomarker Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 26: Imaging Biomarker Market By Technology, Revenue & Volume, By Positron Emission Tomography, 2023-2030 ($)
Table 27: Imaging Biomarker Market By Technology, Revenue & Volume, By Ultrasound, 2023-2030 ($)
Table 28: Imaging Biomarker Market By Technology, Revenue & Volume, By Magnetic Resonance Imaging, 2023-2030 ($)
Table 29: Imaging Biomarker Market By Technology, Revenue & Volume, By Computed Tomography, 2023-2030 ($)
Table 30: Imaging Biomarker Market By Technology, Revenue & Volume, By Single-Photon Emission Computed Tomography, 2023-2030 ($)
Table 31: Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 32: Imaging Biomarker Market By Application, Revenue & Volume, By Personalized Medicines, 2023-2030 ($)
Table 33: Imaging Biomarker Market By Application, Revenue & Volume, By Drug Discovery and Development, 2023-2030 ($)
Table 34: Imaging Biomarker Market By Application, Revenue & Volume, By Molecular Diagnostics, 2023-2030 ($)
Table 35: Imaging Biomarker Market By Application, Revenue & Volume, By Drug Formulation, 2023-2030 ($)
Table 36: Imaging Biomarker Market By Application, Revenue & Volume, By Disease Diagnosis, 2023-2030 ($)
Table 37: North America Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 38: North America Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 39: South america Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 40: South america Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 41: Europe Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 42: Europe Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 43: APAC Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 44: APAC Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 45: Middle East & Africa Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 46: Middle East & Africa Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 47: Russia Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 48: Russia Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 49: Israel Imaging Biomarker Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 50: Israel Imaging Biomarker Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 51: Top Companies 2023 (US$) Imaging Biomarker Market, Revenue & Volume
Table 52: Product Launch 2023-2030 Imaging Biomarker Market, Revenue & Volume
Table 53: Mergers & Acquistions 2023-2030 Imaging Biomarker Market, Revenue & Volume
List of Figures:
Figure 1: Overview of Imaging Biomarker Market 2023-2030
Figure 2: Market Share Analysis for Imaging Biomarker Market 2023 (US$)
Figure 3: Product Comparison in Imaging Biomarker Market 2023-2030 (US$)
Figure 4: End User Profile for Imaging Biomarker Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Imaging Biomarker Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Imaging Biomarker Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Imaging Biomarker Market 2023-2030
Figure 8: Ecosystem Analysis in Imaging Biomarker Market 2023
Figure 9: Average Selling Price in Imaging Biomarker Market 2023-2030
Figure 10: Top Opportunites in Imaging Biomarker Market 2023-2030
Figure 11: Market Life Cycle Analysis in Imaging Biomarker Market
Figure 12: GlobalBy Technology Imaging Biomarker Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy Application Imaging Biomarker Market Revenue, 2023-2030 ($)
Figure 14: Global Imaging Biomarker Market - By Geography
Figure 15: Global Imaging Biomarker Market Value & Volume, By Geography, 2023-2030 ($)
Figure 16: Global Imaging Biomarker Market CAGR, By Geography, 2023-2030 (%)
Figure 17: North America Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 18: US Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 19: US GDP and Population, 2023-2030 ($)
Figure 20: US GDP – Composition of 2023, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2023-2030 ($)
Figure 22: Canada Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 23: Canada GDP and Population, 2023-2030 ($)
Figure 24: Canada GDP – Composition of 2023, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 26: Mexico Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 27: Mexico GDP and Population, 2023-2030 ($)
Figure 28: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 30: South America Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 31: Brazil Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 32: Brazil GDP and Population, 2023-2030 ($)
Figure 33: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 35: Venezuela Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 36: Venezuela GDP and Population, 2023-2030 ($)
Figure 37: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 39: Argentina Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 40: Argentina GDP and Population, 2023-2030 ($)
Figure 41: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 43: Ecuador Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 44: Ecuador GDP and Population, 2023-2030 ($)
Figure 45: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 47: Peru Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 48: Peru GDP and Population, 2023-2030 ($)
Figure 49: Peru GDP – Composition of 2023, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 51: Colombia Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 52: Colombia GDP and Population, 2023-2030 ($)
Figure 53: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 55: Costa Rica Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 56: Costa Rica GDP and Population, 2023-2030 ($)
Figure 57: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 59: Europe Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 60: U.K Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 61: U.K GDP and Population, 2023-2030 ($)
Figure 62: U.K GDP – Composition of 2023, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 64: Germany Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 65: Germany GDP and Population, 2023-2030 ($)
Figure 66: Germany GDP – Composition of 2023, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 68: Italy Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 69: Italy GDP and Population, 2023-2030 ($)
Figure 70: Italy GDP – Composition of 2023, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 72: France Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 73: France GDP and Population, 2023-2030 ($)
Figure 74: France GDP – Composition of 2023, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2023-2030 ($)
Figure 76: Netherlands Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 77: Netherlands GDP and Population, 2023-2030 ($)
Figure 78: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 80: Belgium Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 81: Belgium GDP and Population, 2023-2030 ($)
Figure 82: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 84: Spain Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 85: Spain GDP and Population, 2023-2030 ($)
Figure 86: Spain GDP – Composition of 2023, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 88: Denmark Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 89: Denmark GDP and Population, 2023-2030 ($)
Figure 90: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 92: APAC Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 93: China Imaging Biomarker Market Value & Volume, 2023-2030
Figure 94: China GDP and Population, 2023-2030 ($)
Figure 95: China GDP – Composition of 2023, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2023-2030 ($) Imaging Biomarker Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 97: Australia Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 98: Australia GDP and Population, 2023-2030 ($)
Figure 99: Australia GDP – Composition of 2023, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 101: South Korea Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 102: South Korea GDP and Population, 2023-2030 ($)
Figure 103: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 105: India Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 106: India GDP and Population, 2023-2030 ($)
Figure 107: India GDP – Composition of 2023, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2023-2030 ($)
Figure 109: Taiwan Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 110: Taiwan GDP and Population, 2023-2030 ($)
Figure 111: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 113: Malaysia Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 114: Malaysia GDP and Population, 2023-2030 ($)
Figure 115: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 117: Hong Kong Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 118: Hong Kong GDP and Population, 2023-2030 ($)
Figure 119: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 121: Middle East & Africa Imaging Biomarker Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 122: Russia Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 123: Russia GDP and Population, 2023-2030 ($)
Figure 124: Russia GDP – Composition of 2023, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 126: Israel Imaging Biomarker Market Value & Volume, 2023-2030 ($)
Figure 127: Israel GDP and Population, 2023-2030 ($)
Figure 128: Israel GDP – Composition of 2023, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 130: Entropy Share, By Strategies, 2023-2030* (%) Imaging Biomarker Market
Figure 131: Developments, 2023-2030* Imaging Biomarker Market
Figure 132: Company 1 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 133: Company 1 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 134: Company 1 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 135: Company 2 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 136: Company 2 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 137: Company 2 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 138: Company 3 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 139: Company 3 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 140: Company 3 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 141: Company 4 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 142: Company 4 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 143: Company 4 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 144: Company 5 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 145: Company 5 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 146: Company 5 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 147: Company 6 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 148: Company 6 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 149: Company 6 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 150: Company 7 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 151: Company 7 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 152: Company 7 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 153: Company 8 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 154: Company 8 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 155: Company 8 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 156: Company 9 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 157: Company 9 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 158: Company 9 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 159: Company 10 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 160: Company 10 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 161: Company 10 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 162: Company 11 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 163: Company 11 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 164: Company 11 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 165: Company 12 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 166: Company 12 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 167: Company 12 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 168: Company 13 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 169: Company 13 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 170: Company 13 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 171: Company 14 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 172: Company 14 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 173: Company 14 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)
Figure 174: Company 15 Imaging Biomarker Market Net Revenue, By Years, 2023-2030* ($)
Figure 175: Company 15 Imaging Biomarker Market Net Revenue Share, By Business segments, 2023 (%)
Figure 176: Company 15 Imaging Biomarker Market Net Sales Share, By Geography, 2023 (%)